Antitrust Antitrust

Director's ban over drug-supply abuses bears out CMA's appetite to go after bosses

By Victoria Ibitoye
  • 04 Mar 2020 08:18
  • 29 May 2020 04:23
The banning of a senior King Pharmaceuticals executive over competition abuses in the supply of an antidepressant brings the UK antitrust regulator’s total director disqualifications to 13 and reflects its continuing appetite to target company bosses.

The Competition and Markets Authority today fined four drugmakers a total of 3.4 million pounds ($4.3 million) after

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments

TAKE A FREE TRIAL

Latest News